Five‑year outcomes of a phase II study of adjuvant chemotherapy with S‑1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)

Kazumasa Fujitani, Shigeyuki Tamura, Yutaka Kimura, Jin Matsuyama, Hiroshi Imamura, Kazuyoshi Yamamoto, Junya Fujita, Shohei Iijima, Shugo Ueda, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh, on behalf of the Osaka Gastrointestinal Cancer Chemotherapy Study Group

Gastric Cancer 30 October 2019